Show
Sort by
-
Personalized medicine for allergy treatment : allergen immunotherapy still a unique and unmatched model
-
Cabbage and fermented vegetables : from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19
-
Effect of dupilumab on patient-reported sleep outcomes in patients with severe asthma
-
Effect of dupilumab on improving physical activity in patients with severe asthma
-
- Journal Article
- A1
- open access
ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy
-
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite induced allergic rhinitis : an international, double-blind, placebo-controlled, randomized phase III clinical trial
-
Differentiation of COVID‐19 signs and symptoms from allergic rhinitis and common cold : an ARIA‐EAACI‐GA(2)LEN consensus
-
- Journal Article
- A1
- open access
Nrf2-interacting nutrients and COVID-19 : time for research to develop adaptation strategies
-
Dupilumab improves patient-reported breathing in oral corticosteroid-dependent severe asthma
-
Next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence